Pulse Biosciences Q3 EPS $(0.21) Down From $(0.15) YoY
Portfolio Pulse from Benzinga Newsdesk
Pulse Biosciences reported a Q3 EPS loss of $(0.21), a 40% increase in losses compared to $(0.15) per share from the same period last year.
October 30, 2024 | 8:53 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pulse Biosciences reported a Q3 EPS loss of $(0.21), which is a 40% increase in losses compared to the same period last year. This indicates a worsening financial performance.
The reported increase in EPS losses suggests deteriorating financial health, which is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100